TNFSF11 and arthritic joint disease: Interestingly, a recent study reported that while tacrolimus, a macrolide immunosuppressant that chiefly interferes with T cell activation, was found to decrease RANKL expression in an arthritis mice model compared to control mice, tacrolimus significantly induced SOCS3 mRNA expression in the arthritis model (47).